Last reviewed · How we verify
fiblast,gelatin sponge,fibrin glue
fiblast,gelatin sponge,fibrin glue is a Small molecule drug developed by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan. It is currently in Phase 3 development.
At a glance
| Generic name | fiblast,gelatin sponge,fibrin glue |
|---|---|
| Sponsor | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fiblast,gelatin sponge,fibrin glue CI brief — competitive landscape report
- fiblast,gelatin sponge,fibrin glue updates RSS · CI watch RSS
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan portfolio CI
Frequently asked questions about fiblast,gelatin sponge,fibrin glue
What is fiblast,gelatin sponge,fibrin glue?
fiblast,gelatin sponge,fibrin glue is a Small molecule drug developed by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan.
Who makes fiblast,gelatin sponge,fibrin glue?
fiblast,gelatin sponge,fibrin glue is developed by Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (see full Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan pipeline at /company/translational-research-center-for-medical-innovation-kobe-hyogo-japan).
What development phase is fiblast,gelatin sponge,fibrin glue in?
fiblast,gelatin sponge,fibrin glue is in Phase 3.